Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency

Clinical Endocrinology

Volumn 52, Issue 5, 2000, Pages 537-542

  Murray, R D ^a   Howell, S J ^a   Lissett, C A ^a   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BODY WEIGHT; DISEASE SEVERITY; DOSE CALCULATION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LINEAR MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; STATISTICS, NONPARAMETRIC;

EID: 0034043541     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.00971.x     Document Type: Article

References (23)

1. Abs, R., Bengtsson, B.-A., Hernberg-Stahl, E., Monson, J.P., Tauber, J., Wilton, P. & Wuster, C. (1999) GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clinical Endocrinology, 50, 703-713.
2. Carroll, P.V., Christ, E.R., Bengtsson, B.A., Carlsson, L., Christiansen, J.S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., Sonksen, P.H., Tanaka, T. & Thorne, M. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. Journal of Clinical Endocrinology and Metabolism, 83, 382-395.
3. Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Hennekens, C.H. & Pollak, M. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study [see comments]. Science, 279, 563-566.
4. Chipman, J.J., Attanasio, A.F., Birken, M.A., Bates, P.C., Webb, S. & Lamberts, S.W. (1997) The safety profile of GH replacement therapy in adults. Clinical Endocrinology, 46, 473-481.
5. de Boer, H., Blok, G.J., Popp Snijders, C., Stuurman, L., Baxter, R.C. & van der Veen, E. (1996) Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. Journal of Clinical Endocrinology and Metabolism, 81, 1371-1377.
6. de Boer, H., Blok, G.J. & Van der Veen, E.A. (1995a) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
7. de Boer, H., Blok, G.J., Voerman, B., de Vries, P., Popp Snijders, C. & van der Veen, E. (1995b) The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. Journal of Clinical Endocrinology and Metabolism, 80, 2069-2076.
8. Drake, W.M., Coyte, D., Camacho Hubner, C., Jivanji, N.M., Kaltsas, G., Wood, D.F., Trainer, P.J., Grossman, A.B., Besser, G.M. & Monson, J.P. (1998) Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 83, 3913-3919.
9. Growth Hormone Research Society (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 379-381.
10. Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Speizer, F.E. & Pollak, M. (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer [see comments]. Lancet, 351, 1393-1396.
11. Holmes, S.J., Economou, G., Whitehouse, R.W., Adams, J.E. & Shalet, S.M. (1994) Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 78, 669-674.
12. Holmes, S.J. & Shalet, S.M. (1995) Which adults develop side-effects of growth hormone replacement? Clinical Endocrinology, 43, 143-149.
13. Howell, S.J., Rahim, A. & Shalet, S.M. (1999) Dose Titration and Monitoring GH Treatment in the Adult. In Growth Hormone (ed. by B.-A. Bengtsson), pp. 281-290. Kluwer Academic, Massachusetts.
14. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism, 73, 1081-1088.
15. Janssen, Y.J., Frolich, M. & Roelfsema, F. (1997) A low starting dose of genotropin in growth hormone-deficient adults. Journal of Clinical Endocrinology and Metabolism, 82, 129-135.
16. Johannsson, G., Rosen, T. & Bengtsson, B.A. (1997) Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults. Clinical Endocrinology, 47, 571-581.
17. Jorgensen, J.O., Pedersen, S.A., Thuesen, L., Jorgensen, J., Ingemann Hansen, T., Skakkebaek, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1, 1221-1225.
18. Moller, J., Jorgensen, J.O., Lauersen, T., Frystyk, J., Naeraa, R.W., Orskov, H. & Christiansen, J.S. (1993) Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters [see comments]. Clinical Endocrinology, 39, 403-408.
19. Murray, R.D., Skillicorn, C.J., Howell, S.J., Lissett, C.A., Rahim, A. & Shalet, S.M. (1999) Dose titration and patient selection increases the efficacy of GH replacement in GHD adults. Clinical Endocrinology, 50, 749-757.
20. Rosen, T. & Bengtsson, B.A. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
21. Rosen, T., Wiren, L., Wilhelmsen, L., Wiklund, I. & Bengtsson, B.A. (1994) Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology, 40, 111-116.
22. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
23. van den Berg, G., Veldhuis, J.D., Frolich, M. & Roelfsema, F. (1996) An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. Journal of Clinical Endocrinology and Metabolism, 81, 2460-2467.